Krista L here . Lentine, M.D., Tag A. Schnitzler, Ph.D., Huiling Xiao, M.S., Georges Saab, M.D., Paolo R. Salvalaggio, M.D., Ph.D., David Axelrod, M.D., Connie L. Davis, M.D., Kevin C. Abbott, M.D., M.P.H., and Daniel C. Brennan, M.D.: Racial Variation in Medical Outcomes among Living Kidney Donors Living kidney transplantation is considered to offer patients with end-stage renal disease the best chance for dialysis-free survival.1 In 2006, approximately 27,000 transplantations from registered living kidney donors had been performed worldwide,2 and living donors supplied nearly 40 percent of kidney transplants in the United States.3 Most evidence concerning the safety of living kidney donation for donors derives from single-center research with limited statistical power and few nonwhite donors.4 In a recently available study, investigators at the University of Minnesota accomplished high ascertainment of long-term individual and renal survival and reported no undesireable effects of living kidney donation on life span or risk of end-stage renal disease, as compared with survey data from the general U.S.
Patient 3 had a rise of 3 log devices in visual sensitivity, which peaked 1 year after treatment and declined, although patches of improved visual sensitivity remained at 4.5 years after treatment, the most recent time point assayed. We noticed a subsequent decline in the region of improved sensitivity in every patients; the decline in Patient 3 occurred earlier than in the other sufferers. Relationship between Visible Sensitivity and the Outer Nuclear Layer We determined the topographic relationship between visual function and photoreceptor framework in part of the treatment zone in Patients 1 and 3 . Topographic maps of the thickness of the outer nuclear level in Sufferers 1 and 3, across a broad extent of central retina that included portion of the superior treated area, are shown in Physique 2A.